Friday, September 28
Breakfast
6:30 AM-7:45 AM

Friday, September 28
Lunch
11:45 AM-1:00 PM

Saturday, September 29
Breakfast
6:45 AM-8:00 AM

Saturday, September 29
Lunch
11:30 AM-12:45 PM

Sunday, September 30
Breakfast
7:00 AM-8:15 AM

Back to home

2007 Agenda: 2008 Agenda will be announced soon

SATURDAY, SEPTEMBER 29
Breakfast, 6:45 AM-8:00 AM

Enhancing Antitumor Activity by Incorporating Anti-Angiogenic Strategies

• Describe the rationale for targeting angiogenesis as a therapeutic strategy for treating cancer

• Describe the results of clinical trials incorporating vascular endothelial growth factor antibody (anti-VEGF) alone or with chemotherapy as treatment of advanced breast cancer

• Describe the expected side effects associated with anti-VEGF therapy

• Describe the rationale for ongoing clinical trials incorporating anti-angiogenenic agents

Sandra Swain, MD
Washington Cancer Institute

Kimberly Blackwell, , MD
Duke University Comprehensive Cancer Center

Moderator
Mary Cianfrocca, DO
Robert H. Lurie Comprehensive Cancer Center of Northwestern UniversityD

Register Now

This activity has been approved for 1.25 AMA PRA Category 1 Credit(s)™.

Back to Top